{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T18:38:53Z","timestamp":1778611133336,"version":"3.51.4"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.oftale.2023.11.001","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T22:09:47Z","timestamp":1699308587000},"page":"67-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Protocol for the treatment of cystoid macular edema secondary to retinitis pigmentosa and other inherited retinal dystrophies"],"prefix":"10.1016","volume":"99","author":[{"given":"J.","family":"Catal\u00e0-Mora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.F.","family":"Santamar\u00eda \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Kyriakou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Alforja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Barraso Rodrigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.B.","family":"Blasco Palacio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Casaroli-Marano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Cobos Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.","family":"Coco Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Esmerado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Garc\u00eda Tirado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"G\u00f3mez-Benlloch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.A.","family":"Rodr\u00edguez Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Vilaplana Mira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oftale.2023.11.001_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100975","article-title":"Early and late stage gene therapy interventions for inherited retinal degenerations","volume":"86","author":"Botto","year":"2022","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.oftale.2023.11.001_bib0010","article-title":"Management of Cystoid Macular Edema in Retinitis Pigmentosa: A Systematic Review and Meta-Analysis","volume":"9","author":"Chen","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.oftale.2023.11.001_bib0015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000455281","article-title":"Retinitis Pigmentosa and Other Dystrophies","volume":"58","author":"Mrejen","year":"2017","journal-title":"Dev Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276629","article-title":"Anatomical and functional correlates of cystic macular edema in retinitis pigmentosa","volume":"17","author":"Ruff","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.oftale.2023.11.001_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2022.101092","article-title":"Non-vasogenic cystoid maculopathies","volume":"91","author":"Gaudric","year":"2022","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.oftale.2023.11.001_bib0030","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.survophthal.2012.11.006","article-title":"Treatment of cystic macular lesions in hereditary retinal dystrophies","volume":"58","author":"Salvatore","year":"2013","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/bjophthalmol-2016-309376","article-title":"Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention","volume":"101","author":"Strong","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0040","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/bjo.84.5.542","article-title":"Macular oedema: The role of soluble mediators","volume":"84","author":"Kent","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/bjo.62.3.183","article-title":"Immunological studies in retinitis pigmentosa associated with retinal vascular leakage","volume":"62","author":"Spalton","year":"1978","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0050","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00417-006-0516-y","article-title":"M\u00fcller cells as players in retinal degeneration and edema","volume":"245","author":"Reichenbach","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0055","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/IAE.0000000000000010","article-title":"Prevalence and spatial distribution of cystoid spaces in retinitis pigmentosa: investigation with spectral domain optical coherence tomography","volume":"34","author":"Makiyama","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.oftale.2023.11.001_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2022.101147","article-title":"Advances in understanding the molecular structure of retinoschisin while questions remain of biological function","volume":"95","author":"Heymann","year":"2023","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.oftale.2023.11.001_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.101038","article-title":"Retinal cadherins and the retinal cadherinopathies: Current concepts and future directions","volume":"90","author":"Yusuf","year":"2022","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.oftale.2023.11.001_bib0070","first-page":"179","article-title":"Investigations of antiretinal antibodies in pigmentary retinopathy and other retinal degenerations","volume":"94","author":"Heckenlively","year":"1996","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.oftale.2023.11.001_bib0075","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0161-6420(03)00259-8","article-title":"Vitreoretinal surgery for cystoid macular edema associated with retinitis pigmentosa","volume":"110","author":"Garc\u00eda-Arum\u00ed","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftale.2023.11.001_bib0080","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1167\/iovs.12-10149","article-title":"Correlations between spectral-domain OCT measurements and visual acuity in cystoid macular edema associated with retinitis pigmentosa","volume":"54","author":"Kim","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oftale.2023.11.001_bib0085","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/IAE.0000000000003286","article-title":"Recurrence rate of cystoid macular edema with topical dorzolamide treatment and its risk factors in retinitis pigmentosa","volume":"42","author":"Shimokawa","year":"2022","journal-title":"Retina"},{"key":"10.1016\/j.oftale.2023.11.001_bib0090","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.survophthal.2017.09.009","article-title":"Treatment of cystoid macular edema secondary to retinitis pigmentosa: A systematic review","volume":"63","author":"Bakthavatchalam","year":"2018","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0095","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archopht.1989.01070020519031","article-title":"Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa","volume":"107","author":"Fishman","year":"1989","journal-title":"Arch Ophthalmol (Chicago, Ill 1960)"},{"key":"10.1016\/j.oftale.2023.11.001_bib0100","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.optm.2008.01.026","article-title":"Review and update: current treatment trends for patients with retinitis pigmentosa","volume":"80","author":"Shintani","year":"2009","journal-title":"Optometry"},{"key":"10.1016\/j.oftale.2023.11.001_bib0105","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s004170050175","article-title":"The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema","volume":"236","author":"Moldow","year":"1998","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0110","unstructured":"AEMPS. Edemox. Ficha t\u00e9cnica. Published 2017 [Accessed 12 January 2023]. Available from: https:\/\/cima.aemps.es\/cima\/pdfs\/es\/ft\/24408\/FT_24408.pdf."},{"key":"10.1016\/j.oftale.2023.11.001_bib0115","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00006982-199717030-00009","article-title":"Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa","volume":"17","author":"Grover","year":"1997","journal-title":"Retina"},{"key":"10.1016\/j.oftale.2023.11.001_bib0120","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/bjo.2006.107466","article-title":"Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa","volume":"91","author":"Fishman","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0125","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archophthalmol.2009.398","article-title":"Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis","volume":"128","author":"Genead","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0130","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ajo.2005.12.030","article-title":"Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa","volume":"141","author":"Grover","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0135","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00417-011-1904-5","article-title":"The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa","volume":"250","author":"Ikeda","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2021.106578","article-title":"Nonsteroidal anti-inflammatory drugs for retinal neurodegenerative diseases","volume":"156","author":"Chen","year":"2021","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.oftale.2023.11.001_bib0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000368052","article-title":"Comparison of topical dorzolamide and ketorolac treatment for cystoid macular edema in retinitis pigmentosa and Usher\u2019s syndrome","volume":"233","author":"Lemos Reis","year":"2015","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.oftale.2023.11.001_bib0150","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jcrs.2007.05.015","article-title":"In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac","volume":"33","author":"Walters","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.oftale.2023.11.001_bib0155","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0420.2005.00395.x","article-title":"Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa","volume":"83","author":"Ozdemir","year":"2005","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.oftale.2023.11.001_bib0160","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/archopht.125.6.759","article-title":"Treatment of cystoid macular edema in retinitis pigmentosa with intravitreal triamcinolone","volume":"125","author":"Scorolli","year":"2007","journal-title":"Arch Ophthalmol (Chicago, Ill 1960)"},{"key":"10.1016\/j.oftale.2023.11.001_bib0165","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00417-012-2249-4","article-title":"Intravitreal dexamethasone implant (Ozurdex) for macular edema secondary to retinitis pigmentosa","volume":"251","author":"Srour","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0170","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1089\/jop.2018.0153","article-title":"Dexamethasone Implant Produces Better Outcomes than Oral Acetazolamide in Patients with Cystoid Macular Edema Secondary to Retinitis Pigmentosa","volume":"36","author":"Veritti","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.oftale.2023.11.001_bib0175","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/IAE.0000000000002589","article-title":"A randomized paired-eye trial of intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa","volume":"40","author":"Park","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.oftale.2023.11.001_bib0180","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00417-017-3660-7","article-title":"Intravitreal dexamethasone implant for recalcitrant cystoid macular edema secondary to retinitis pigmentosa: A pilot study","volume":"255","author":"Sudhalkar","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0185","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2147\/DDDT.S403259","article-title":"Intravitreal Fluocinolone Acetonide Implant (ILUVIEN\u00ae) for the Treatment of Retinal Conditions. A Review of Clinical Studies","volume":"17","author":"Mushtaq","year":"2023","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.oftale.2023.11.001_bib0190","article-title":"Fluocinolone acetonide implant (Iluvien\u00ae) for macular edema associated with retinitis pigmentosa: A case report","author":"Jomaa","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0195","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6678364","article-title":"Off-Label Use of 0.19 mg Fluocinolone Acetonide Intravitreal Implant: A Systematic Review","volume":"2021","author":"Ribeiro","year":"2021","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0200","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/jop.2009.0089","article-title":"Intravitreal ranibizumab in the treatment of cystoid macular edema associated with retinitis pigmentosa","volume":"25","author":"Artunay","year":"2009","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.oftale.2023.11.001_bib0205","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1136\/bjophthalmol-2019-315152","article-title":"Prospective exploratory study to assess the safety and efficacy of aflibercept in cystoid macular oedema associated with retinitis pigmentosa","volume":"104","author":"Strong","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0210","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/02713680802710692","article-title":"Intravitreal bevacizumab (Avastin) injection in retinitis pigmentosa","volume":"34","author":"Yuzbasioglu","year":"2009","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.oftale.2023.11.001_bib0215","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10103-020-03031-0","article-title":"Management of cystoid macular edema secondary to retinitis pigmentosa via subliminal micropulse yellow laser","volume":"36","author":"Arslan","year":"2021","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.oftale.2023.11.001_bib0220","article-title":"Tocilizumab resolves refractory macular edema associated to retinitis pigmentosa","author":"M\u00e9ndez-Mart\u00ednez","year":"2022","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.oftale.2023.11.001_bib0225","article-title":"Oral minocycline for the treatment of retinitis pigmentosa-associated cystoid macular edema: results of a phase I\/II clinical trial","volume":"8","author":"Dave","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0230","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/08820538.2016.1228404","article-title":"Management of Cystoid Macular Edema in Retinitis Pigmentosa","volume":"32","author":"Huckfeldt","year":"2017","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186180","article-title":"Efficacy of carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa: A meta-analysis","volume":"12","author":"Huang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.oftale.2023.11.001_bib0240","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/13816810.2019.1660381","article-title":"Efficacy of topical brinzolamide in children with retinal dystrophies","volume":"40","author":"Scruggs","year":"2019","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.oftale.2023.11.001_bib0245","first-page":"192","article-title":"Pediatric Uveitis","volume":"7","author":"Chan","year":"2018","journal-title":"Asia-Pacific J Ophthalmol (Phila)"},{"key":"10.1016\/j.oftale.2023.11.001_bib0250","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/eye.2011.91","article-title":"X-linked retinoschisis maculopathy treated with topical dorzolamide, and relationship to genotype","volume":"25","author":"Khandhadia","year":"2011","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oftale.2023.11.001_bib0255","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1167\/iovs.16-20078","article-title":"Carbonic anhydrase inhibitors for the treatment of cystic macular lesions in children with X-linked juvenile retinoschisis","volume":"57","author":"Verbakel","year":"2016","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.oftale.2023.11.001_bib0260","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1055\/s-0040-1708847","article-title":"Update in Pediatric Pseudotumor Cerebri Syndrome","volume":"40","author":"Beres","year":"2020","journal-title":"Semin Neurol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0265","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.2014.3312","article-title":"NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial","volume":"311","author":"Wall","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.oftale.2023.11.001_bib0270","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/IAE.0b013e3181e587f9","article-title":"The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis","volume":"31","author":"Thobani","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.oftale.2023.11.001_bib0275","first-page":"2","article-title":"Brinzolamide therapy in cystoid macular edema secondary to retinitis pigmentosa | Retinitis pigmentozaya bagli kistoid mak?la? deminde topikal brinzolamid tedavisi","volume":"21","author":"Alkin","year":"2013","journal-title":"Retina-Vitreus"},{"key":"10.1016\/j.oftale.2023.11.001_bib0280","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.4103\/ijo.IJO_2916_20","article-title":"Cataract surgery in retinitis pigmentosa","volume":"69","author":"Chatterjee","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0285","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6699103","article-title":"A Review of Complicated Cataract in Retinitis Pigmentosa: Pathogenesis and Cataract Surgery","volume":"2020","author":"Hong","year":"2020","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0290","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1111\/aos.13250","article-title":"Anterior lens epithelium in cataract patients with retinitis pigmentosa - scanning and transmission electron microscopy study","volume":"95","author":"Andjelic","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0295","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6699103","article-title":"A Review of Complicated Cataract in Retinitis Pigmentosa: Pathogenesis and Cataract Surgery","volume":"2020","author":"Hong","year":"2020","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0300","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0161-6420(82)34700-4","article-title":"Cataract surgery in retinitis pigmentosa patients","volume":"89","author":"Bastek","year":"1982","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftale.2023.11.001_bib0305","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.oret.2022.04.018","article-title":"Risk of Cystoid Macular Edema after Cataract Surgery in Retinitis Pigmentosa: An Analysis of United States Claims from 2010 to 2018","volume":"6","author":"Antonio-Aguirre","year":"2022","journal-title":"Ophthalmol Retin"},{"key":"10.1016\/j.oftale.2023.11.001_bib0310","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/bjo.85.8.936","article-title":"Outcome of cataract surgery in patients with retinitis pigmentosa","volume":"85","author":"Jackson","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0315","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ajo.2017.05.026","article-title":"Evaluating Structural Progression of Retinitis Pigmentosa After Cataract Surgery","volume":"180","author":"De Rojas","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0320","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jcjo.2017.04.002","article-title":"Cataract surgery outcomes and complications in retinal dystrophy patients","volume":"52","author":"Davies","year":"2017","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.001_bib0325","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.preteyeres.2018.03.005","article-title":"Non-syndromic retinitis pigmentosa","volume":"66","author":"Verbakel","year":"2018","journal-title":"Prog Retin Eye Res"}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173579423001767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173579423001767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:29:27Z","timestamp":1761881367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173579423001767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2173579423001767"],"URL":"https:\/\/doi.org\/10.1016\/j.oftale.2023.11.001","relation":{},"ISSN":["2173-5794"],"issn-type":[{"value":"2173-5794","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protocol for the treatment of cystoid macular edema secondary to retinitis pigmentosa and other inherited retinal dystrophies","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftale.2023.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2023.09.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedad Espa\u00f1ola de Oftalmolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}